Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
This study has been withdrawn prior to enrollment.
(insufficient enrollment)
Sponsor:
Charite University, Berlin, Germany
Collaborators:
Wyeth is now a wholly owned subsidiary of Pfizer
Mundipharma K.K.
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01170052
First received: July 14, 2010
Last updated: March 15, 2011
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |